ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998

In brief: Shalala Meets HIV-Infected Children; Einstein’s Kornblith Moves To PCI; Yang Leaves Center

March 12, 1993

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA

June 20, 1986